Application note: Reliable Single Cell Cloning with Advanced Microfluidic Dispensing
Find out how to accelerate and improve selective single cell cloning with advanced microfluidic dispensing.
List view / Grid view
Find out how to accelerate and improve selective single cell cloning with advanced microfluidic dispensing.
Peptide-based nanoparticles have been designed which can suppress pancreatic cancer growth without the toxic side effects.
A new mechanism by which cancer cells become resistant to chemotherapy has been found which could lead to a new target for drugs.
A new study, which has shown that the congenital heart condition LVNC could be be caused by signalling defects, may lead to potential therapies.
A new study into the enzyme Cdc34 may make it possible to target the enzyme specifically to develop new cancer therapeutics.
A study has found a selective inhibitor for an enzyme that allows cancer cells to mutate and become resistant to treatments.
A simple and direct method of introducing lipids into protein has been developed using palladium as a catalyst.
Researchers have developed CRISPR-Cas13 enzyme-based technology that can be programmed to both detect and destroy RNA-based viruses in human cells.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
Scientists in the US have identified a particular bacterial strain, Segmented filamentous bacteria (SFB), that can prevent and cure rotavirus in mice.
A genetic mutation that causes idiopathic pulmonary fibrosis has been identified and could lead to a new therapeutic approach to treating the disease.
A new algorithm has been developed which personalises which cancer mutations are best targets for immunotherapy.
A new study has shown the possibility of using RNA splicing as a potential molecular target for Alzheimer's disease.
Disruption of the MFF-VDAC1 complex could lead to a potential therapeutic target for cancer.
A study has demonstrated that a certain protein is critical in the decline of muscle regeneration, with the researchers also showing how to inhibit this process in mice.